Evaluation of diet and exercise in prostate cancer-related fatigue
- Conditions
- Prostate Cancer treated with Androgen Deprivation therapyCancer-related fatigueDiet and Nutrition - Other diet and nutrition disordersPhysical Medicine / Rehabilitation - PhysiotherapyCancer - Prostate
- Registration Number
- ACTRN12615000512527
- Lead Sponsor
- Brenton Baguley
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 116
If you have prostate cancer and are currently being treated with androgen deprivation therapy, for longer than 3 months.
1. Currently smoke
2. Body mass index above 18.5 kg/m2 (underweight) or equal/below 35.0 kg/m2 (obese class II)
3. Current infection
4. Bone metastases; excluded for exercise safety
5. Currently taking supplements other than singe multivitamin; unless for medical purposes.
7. Currently undertaking high intensity exercise
8. Have any medical conditions (musculoskeletal, cardiopulmonary or metabolic) that would prevent their safe participation in the exercises program
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prostate cancer-related fatigue questionnaires measured by; functional assessment of cancer therapy: fatigue [At baseline and weeks 8, 12, 20 (and weeks 24 and 28 for the usual care group). ];Prostate cancer-related quality of life questionnaires measured by; The European organization for Research and Treatment of Cancer Quality of Life Questionnaire; EORTC QLQ – C30,[At baseline and weeks 8, 12, 20 (and weeks 24 and 28 for the usual care group).];Prostate cancer-related quality of life questionnaires measured by; EORTC QLQ – PR25 prostate cancer-specific health-related quality of life self-assessment questionnaire.[At baseline and weeks 8, 12, 20 (and weeks 24 and 28 for the usual care group).]
- Secondary Outcome Measures
Name Time Method